MYO19

Chr 17

myosin XIX

Also known as: MYOHD1

The protein is an actin-based motor that hydrolyzes ATP and localizes to the mitochondrial outer membrane, where it facilitates mitochondrial transport, positioning, and inheritance during cell division. Mutations cause autosomal recessive spastic paraplegia and early-onset developmental and epileptic encephalopathy, affecting the nervous system primarily. The gene shows very low constraint against loss-of-function variants.

OMIMResearchSummary from RefSeq, UniProt
MultiplemechanismLOEUF 1.18
Clinical SummaryMYO19
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
37 unique Pathogenic / Likely Pathogenic· 343 VUS of 500 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.18LOEUF
pLI 0.000
Z-score 0.45
OE 0.94 (0.751.18)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.18Z-score
OE missense 0.98 (0.911.05)
539 obs / 551.1 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.94 (0.751.18)
00.351.4
Missense OE0.98 (0.911.05)
00.61.4
Synonymous OE1.17
01.21.6
LoF obs/exp: 54 / 57.7Missense obs/exp: 539 / 551.1Syn Z: -2.03
DN
0.6550th %ile
GOF
0.7126th %ile
LOF
0.3453th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

500 submitted variants in ClinVar

Classification Summary

Pathogenic31
Likely Pathogenic6
VUS343
Likely Benign79
Benign9
Conflicting1
31
Pathogenic
6
Likely Pathogenic
343
VUS
79
Likely Benign
9
Benign
1
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
31
0
31
Likely Pathogenic
1
1
4
0
6
VUS
18
321
4
0
343
Likely Benign
0
11
1
67
79
Benign
1
3
1
4
9
Conflicting
1
Total203364171469

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

MYO19 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →